SUCRAID

This brand name is authorized in United States.

Active ingredients

The drug SUCRAID contains one active pharmaceutical ingredient (API):

`1`	Sacrosidase UNII `8A7F670F2Y` - SACROSIDASE
	Sacrosidase is a liquid enzyme preparation derived from baker’s yeast (Saccharomyces cerevisiae) used for the treatment of genetically determined sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID).
	Read more about Sacrosidase

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SUCRAID Oral solution	MPI, US: SPL/Old	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	67871-111

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.